facebook
twitter
rss
account
search
search
 

FDA OK's new pain therapy

Jan. 26, 2010 at 12:20 PM   |   Comments

WASHINGTON, Jan. 26 (UPI) -- The U.S. Food and Drug Administration says it has approved a morphine sulfate oral solution to treat moderate to severe pain in opioid-tolerant patients.

The FDA said the medicine has been used for many years to relieve acute and chronic pain, but the new concentration of morphine -- 100 milligrams per 5 milliliters or 20 milligrams per 1 milliliter -- had not been FDA-approved until now.

The action is part of the FDA's unapproved drugs initiative, designed to make sure marketed drugs meet current FDA standards.

The morphine sulfate oral solution is manufactured by Roxane Laboratories of Columbus, Ohio.

© 2010 United Press International, Inc. All Rights Reserved. Any reproduction, republication, redistribution and/or modification of any UPI content is expressly prohibited without UPI's prior written consent.
Recommended UPI Stories
Featured UPI Collection
trending
Notable deaths of 2014 [PHOTOS]

Notable deaths of 2014 [PHOTOS]

Most Popular
1
You've got mites on your face, and so does everyone else
2
Panda fakes pregnancy to get more food [UPDATED]
3
Tech industry All Stars developing 'Star Trek'-style communication badges
4
Weird 'walking' fish holds evolutionary clues
5
Latvia boasts world's first net for migrating bats
Trending News
Video
x
Feedback